Novartis, a global brand, is at the forefront of producing therapeutic breakthroughs in medicine for patients. Through their research arm, Novartis Institutes for BioMedical Research (NIBR), they harness the power of new technologies to develop innovative treatments and advance healthcare. Novartis offers a wide range of products and services encompassing various therapeutic areas. They specialize in Hematology, Neuroscience, and Solid tumors, aiming to address significant health challenges and improve patient outcomes. Additionally, their subsidiary, Sandoz, focuses on providing high-quality generic pharmaceuticals and biosimilars. Committed to diversity, equity, and inclusion, Novartis places people and culture at the heart of their operations. They have a strong governance and community inclusivity framework in place, ensuring that patients and caregivers receive the support they need. Moreover, Novartis prioritizes manufacturing quality and product safety, maintaining rigorous standards through their audit program and quality management system. Overall, Novartis remains dedicated to transforming breakthrough science into transformative treatments, making a positive impact on global health while championing sustainability and ethical behavior.